IPO and Trading News

• Page 1 of 1 (8 items) 1 

• Top 20 Molecular Millionaires
  Which biopharma company leaders are raking in the most in shares?
• M&A Likely to Continue Growing Along with Deal Premiums and Multiples
  Slow comeback of IPO market will keep companies looking for opportunities to be acquired.
• Buyout Options Gaining a Foothold in Deals Means that More than the Price Is Right
  Buyout rights are attractive to smaller firms as they offer up-front payments and a longer-term path to liquidity.
• Venture Capital Continues Its Migration in Q1 2012 as Investors Seek Safer Bets
  In terms of IPOs, seven companies went public raising $480 million compared with $521 million raised by eight IPOs in the year-ago quarter.
• 2011 IPO Window for Biotechs Lets Through Fewer Companies
  Just 13 firms went public compared to 16 in 2010, but discounts were smaller.
• What Does It Take to Swing the IPO Window Open for Biotechs?
  Suggestions include selling at a discount at a time when there is a rising investor fan-base for social media.
• Early-Stage Investors Hedge Their Bets with Medical Devices
  VCs are looking for a quicker return on their investments with less risk involved.
• BIO Investor: IPOs, Financing, and the Need for New Flu Treatments
  Presenters believe that M&A will shift to deals between biotech firms and that new technologies will improve vaccine production.

• Page 1 of 1 (8 items) 1